<article>Australian venture capital firms <a href="https://www.dealstreetasia.com/?s=Brandon+Capital" target="_blank" rel="noopener noreferrer">Brandon Capital</a> and <a style="color: #000080;" href="https://www.dealstreetasia.com/?s=uniseed" target="_blank" rel="noopener noreferrer">Uniseed</a> have invested up to $16 million in clinical-stage biotechnology startup <a style="color: #000080;" href="https://www.dealstreetasia.com/?s=QUE+Oncology" target="_blank" rel="noopener noreferrer">QUE Oncology Inc</a>. </article>

Australian venture capital firms <a href="https://www.dealstreetasia.com/?s=Brandon+Capital" target="_blank" rel="noopener noreferrer">Brandon Capital</a> and <a style="color: #000080;" href="https://www.dealstreetasia.com/?s=uniseed" target="_blank" rel="noopener noreferrer">Uniseed</a> have invested up to $16 million in clinical-stage biotechnology startup <a style="color: #000080;" href="https://www.dealstreetasia.com/?s=QUE+Oncology" target="_blank" rel="noopener noreferrer">QUE Oncology Inc</a>. 
QUE was established by <a style="color: #000080;" href="https://www.dealstreetasia.com/?s=University+of+Queensland" target="_blank" rel="noopener noreferrer">The University of Queensland (UQ)</a>, and <a style="color: #000080;" href="https://www.dealstreetasia.com/?s=Emory+University" target="_blank" rel="noopener noreferrer">Emory University</a> in Atlanta, USA to develop novel cancer supportive care and anticancer therapies.
UQ said the Series A funding will help QUE further develop its leading drug candidate Q-122 and progress its pre-clinical pipeline.
Q-122 is a new non-hormonal therapy for the treatment of hot flashes in women undergoing endocrine therapy for breast cancers.
Founded in 2013, QUE is a collaboration between UQ’s main commercialisation company <a style="color: #000080;" href="https://www.dealstreetasia.com/?s=UniQuest" target="_blank" rel="noopener noreferrer">UniQuest</a> and Emory University around intellectual property licensed from both universities and with both parties providing seed investment and support.
Uniseed is a venture fund operating at the Universities of Melbourne, Queensland, Sydney &amp; New South Wales, and the <a style="color: #000080;" href="https://www.dealstreetasia.com/?s=CSIRO" target="_blank" rel="noopener noreferrer">CSIRO</a>, with investment capital provided by the five partner research organisations.
UniQuest chief executive officer Dr Dean Moss said the Series A investment was a significant endorsement of the prospects of the company and its programmes.
&#8220;QUE recently completed a successful phase 1b clinical trial of Q-122 where, in some cases, participants reported a 100 per cent reduction in hot flash incidents,&#8221; Dr Moss said.
He asserted QUE could make a real difference to many women around the world.
&#8220;This investment will support the company as it continues to navigate the clinical trial and regulatory processes required to bring this life-changing treatment to the market,&#8221; Dr Moss added.
QUE is also progressing three preclinical projects licensed from UQ researchers Professor Maree Smith, Dr Trent Woodruff, Professor Greg Monteith and Professor Sarah Roberts-Thomson, and collaborator Professor William Denny from the University of Auckland, in the areas of breast cancer, melanoma and cancer pain.
Also Read: <a style="color: #ff0000;" href="https://www.dealstreetasia.com/stories/oneventures-brandon-capital-and-bioscience-managers-chosen-to-manage-australian-375m-life-science-fund-60437/" target="_blank" rel="noopener noreferrer">Australia taps three VC firms to manage $375m lifesciences fund</a>
<a style="color: #ff0000;" href="https://www.dealstreetasia.com/stories/37145-37145/" target="_blank" rel="noopener noreferrer">Uniseed leads $4m investment in probiotics drinks firm PERKii</a>
<a style="color: #ff0000;" href="https://www.dealstreetasia.com/stories/australian-universities-close-20m-commitments-for-uniseed-66714/" target="_blank" rel="noopener noreferrer">Australian varsities close $15m commitments for Uniseed follow-on fund</a>

QUE was established by The University of Queensland (UQ), and Emory University in Atlanta to develop novel cancer supportive care and anticancer therapies.

Australia: Brandon Capital, Uniseed invest $16m in biotech startup QUE

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Australia: Brandon Capital, Uniseed invest $16m in biotech startup QUE

Start your deal-making journey now!

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief